Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
暂无分享,去创建一个
Joos V Lebesque | Markus Alber | Marco Schwarz | Ben J Mijnheer | M. Alber | J. Lebesque | M. Schwarz | E. Damen | B. Mijnheer | Eugène M F Damen
[1] Joos V Lebesque,et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[2] M. Fippel. Efficient particle transport simulation through beam modulating devices for Monte Carlo treatment planning. , 2004, Medical physics.
[3] Issam El-Naqa,et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. , 2004, International journal of radiation oncology, biology, physics.
[4] Radhe Mohan,et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[5] Thomas Guerrero,et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[6] Di Yan,et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.
[7] Joos V Lebesque,et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] L. Boersma,et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] M. V. van Herk,et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[10] Kurt Baier,et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[11] Y. Seppenwoolde. Radiation induced lung damage , 2002 .
[12] M van Herk,et al. Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors. , 2001, International journal of radiation oncology, biology, physics.
[13] M. Alber,et al. Optimization of intensity modulated radiotherapy under constraints for static and dynamic MLC delivery. , 2001, Physics in medicine and biology.
[14] F Nüsslin,et al. A variable fluence step clustering and segmentation algorithm for step and shoot IMRT. , 2001, Physics in medicine and biology.
[15] T Pawlicki,et al. Monte Carlo simulation for MLC-based intensity-modulated radiotherapy. , 2001, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[16] R Mohan,et al. Monte Carlo dose calculations for dynamic IMRT treatments. , 2001, Physics in medicine and biology.
[17] M. Alber,et al. Monte Carlo dose computation for IMRT optimization. , 2000, Physics in medicine and biology.
[18] H Shirato,et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[19] Fridtjof Nüsslin,et al. Hyperion — An integrated IMRT planning tool , 2000 .
[20] R. Jeraj,et al. Monte Carlo-based inverse treatment planning. , 1999, Physics in medicine and biology.
[21] R K Ten Haken,et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.
[22] M. Alber,et al. An objective function for radiation treatment optimization based on local biological measures. , 1999, Physics in medicine and biology.
[23] A Ottolenghi,et al. Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.
[24] R Mohan,et al. Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.
[25] J. Lebesque,et al. The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] J. Fowler. Radiation-induced lung damage: dose-time fractionation considerations. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[28] H. Withers,et al. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.